Paper1163426
Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
Gray R and 5 others. Am Heart J, 1975. Cited by 184 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Papers, record 1163426. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1163426
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heart Failure | Major topic |
| Hemodynamics | Major topic |
| Isosorbide Dinitrate | Major topic |
| Myocardium | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Blood Pressure | |
| Cardiac Output | |
| Coronary Circulation | |
| Drug Evaluation | |
| Female | |
| Heart Rate | |
| Humans | |
| Lactates | |
| Male | |
| Middle Aged | |
| Oxygen Consumption | |
| Pulmonary Circulation | |
| Tablets | |
| Vascular Resistance | |
| Venous Pressure |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 184 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28288687 | Effectiveness of isosorbide dinitrate in cyanide poisoning as a function of the administration timing. | BMC Pharmacol Toxicol | 2017 | https://conductscience.org/library/papers/28288687 | PubMed |
| 19379635 | Invasive monitoring in patients with heart failure. | Curr Cardiol Rep | 2009 | https://conductscience.org/library/papers/19379635 | PubMed |
| 7439242 | Effects and pharmacokinetics of isosorbide dinitrate in normal man. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7439242 | PubMed |
| 7362716 | Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure. | Br Heart J | 1980 | https://conductscience.org/library/papers/7362716 | PubMed |
| 7225252 | Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure. | Br Heart J | 1981 | https://conductscience.org/library/papers/7225252 | PubMed |
| 6804202 | Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use. | Drugs | 1982 | https://conductscience.org/library/papers/6804202 | PubMed |
| 6797546 | Peripheral oedema in patients treated with isosorbide dinitrate. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6797546 | PubMed |
| 6704264 | Acute haemodynamic and metabolic effects of felodipine in congestive heart failure. | Br Heart J | 1984 | https://conductscience.org/library/papers/6704264 | PubMed |
| 3533238 | Vasodilator therapy in the perioperative period. | Can Anaesth Soc J | 1986 | https://conductscience.org/library/papers/3533238 | PubMed |
| 3154699 | Combination of positive inotropic and vasodilating substances in congestive heart failure. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/3154699 | PubMed |
| 3024949 | The treatment of heart failure. A methodological review of the literature. | Drugs | 1986 | https://conductscience.org/library/papers/3024949 | PubMed |
| 2113003 | Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate. | Eur J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2113003 | PubMed |
| 884021 | Vasodilator treatment for acute and chronic heart failure. | Br Heart J | 1977 | https://conductscience.org/library/papers/884021 | PubMed |
| 821578 | Letter: Cardiac failure. | Br Med J | 1976 | https://conductscience.org/library/papers/821578 | PubMed |
| 687485 | Enhancement by isosorbide dinitrate of haemodynamic effects of dopamine in chronic congestive cardiac failure. | Br Heart J | 1978 | https://conductscience.org/library/papers/687485 | PubMed |
| 687484 | Improvement in exercise haemodynamics by isosorbide dinitrate in patients with severe congestive cardiac failure secondary to ischaemic heart disease. | Br Heart J | 1978 | https://conductscience.org/library/papers/687484 | PubMed |
| 534582 | Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure. | Br Heart J | 1979 | https://conductscience.org/library/papers/534582 | PubMed |
| 497982 | Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure. | Can Med Assoc J | 1979 | https://conductscience.org/library/papers/497982 | PubMed |
| 371647 | Comparative haemodynamic and peripheral vasodilator effects of oral and chewable isosorbide dinitrate in patients with refractory congestive cardiac failure. | Br Heart J | 1979 | https://conductscience.org/library/papers/371647 | PubMed |
| 359015 | Methods for the assessment of the effects of drugs on coronary blood flow in man. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/359015 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1163426
GET https://conductscience.org/api/papers/v1/1163426/authors